IQVIA Holdings Inc

IQVHealthcare

Sentinellis Health Score

5.8/10

Moderate concerns

Market Cap

$28.1B

Revenue

$16.3B

P/E Ratio

20.9x

AI Summary

IQVIA provides three core services to life sciences companies: (1) Technology & Analytics Solutions — cloud platforms and data on drug sales, prescribing trends, and patient outcomes across global markets; (2) Research & Development Solutions — clinical trial management, patient recruitment, laboratory services, and genomic testing; (3) Contract Sales & Medical Solutions — outsourced sales teams and patient engagement services for pharmaceutical companies [Yahoo Finance]. Think of them as the company that helps drug makers figure out which medicines are selling where, run clinical trials faster, and get products to market more efficiently.

IQVIA Holdings is a $28.1B healthcare data and clinical research company serving pharmaceutical and biotech clients globally [Yahoo Finance]. The company combines cloud-based analytics, real-world evidence platforms, and clinical trial services — essentially acting as the infrastructure backbone for drug development and commercialization. Recent news highlights strong Q1 earnings, an expanded AI-powered biosimilar partnership with Kexing Biopharm, and growing demand for its data analytics tools [Yahoo Finance].

IQVIA shows solid profitability and cash generation, but carries elevated debt that keeps the overall health score moderate.

Confidence7/10